Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Older HIV drugs are in part to blame for the rising rate, but newer medications, like integrase inhibitors, are not.
One person treated with a broadly neutralizing antibody plus romidepsin remained in remission for 3.7 years.
With further testing, the antiviral proteins might be used as a nasal spray to prevent or treat COVID-19.
PrEP prescriptions are supposed to be free to users now, which could go a long way toward leveling the HIV-prevention playing field.
Telemedicine is an increasingly used to provide convenient PrEP services. But are these programs following U.S. guidelines?
Nearly 200 cases of pediatric hepatitis have now been reported in more than a dozen countries and several states.
When it comes to prevention, Medicaid also plays a role in lowering the burden of cancer among people living with HIV.
Baseline readings in the REPRIEVE study show sex and race differences in electrocardiograph outcomes.
Antiviral drugs that target host cells may work against many existing and future variants of the virus that causes COVID-19.
Currently, fewer than 1 in 10 women eligible for HIV prevention medications are taking them.
A small Spanish study suggests that screening people living with HIV for lung cancer results in a high rate of diagnosis.
The current leading suspect is an adenovirus, but much more remains to be learned.
Anticholinergic medications can lead to cognitive problems and poor coordination, especially in older people.
CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.